Загрузка...
Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice
OBJECTIVE: W1-mAb is a chimpanzee-derived monoclonal antibody to protective antigen that improved survival when administered before anthrax lethal toxin challenge in rats. To better define W1-mAb’s efficacy for anthrax, we administered it after initiation of 24-hr infusions of edema toxin and lethal...
Сохранить в:
| Главные авторы: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3523297/ https://ncbi.nlm.nih.gov/pubmed/21336113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0b013e3182120691 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|